Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients

Published:2010-11-22 Issue:8 Volume:46 Page:1053-1056
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Kobold S,Isernhagen J,Hübel K,Kilic N,Bogner C,Frickhofen N,Bokemeyer C,Fiedler W

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2010264.pdf

Reference11 articles.

1. Daugaard G . Management of poor-prognosis or relapsed germ-cell cancer. BJU Int 2009; 104 (Part B): 1392–1397.

2. Kollmannsberger C, Beyer J, Bokemeyer C . High-dose chemotherapy in nonseminomatous germ cell cancer. BJU Int 2009; 104 (Part B): 1398–1403.

3. Leung AY, Kwong YL . Haematopoietic stem cell transplantation: current concepts and novel therapeutic strategies. Br Med Bull 2010; 93: 85–103.

4. Ford CD, Green W, Warenski S, Petersen FB . Effect of prior chemotherapy on hematopoietic stem cell mobilization. Bone Marrow Transplant 2004; 33: 901–905.

5. DiPersio JF, Uy GL, Yasothan U, Kirkpatrick P . Plerixafor. Nat Rev Drug Discov 2009; 8: 105–106.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of upfront plerixafor use for mobilization in germ cell tumor patients;Hematology, Transfusion and Cell Therapy;2024-03

2. Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation;Frontiers in Oncology;2023-08-28

3. High-dose chemotherapy for relapsed testicular germ cell tumours;Nature Reviews Urology;2022-12-07

4. Addition of plerixafor in poorly mobilized allogeneic stem cell donors;Journal of Clinical Apheresis;2022-05-28

5. Approaches of stem cell mobilization in a large cohort of metastatic germ cell cancer patients;Bone Marrow Transplantation;2022-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3